Rossari Biotech [ROSSARI] vs Tanfac Industries [TANFACIND] Detailed Stock Comparison

Rossari Biotech Ltd.

NSE
Loading...

Tanfac Industries Ltd.

BSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Rossari Biotech Ltd. wins in 8 metrics, Tanfac Industries Ltd. wins in 12 metrics, with 0 ties. Tanfac Industries Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Rossari Biotech Ltd. Tanfac Industries Ltd. Better
P/E Ratio (TTM) 20.79 66.26 Rossari Biotech Ltd.
Price-to-Book Ratio 2.28 14.61 Rossari Biotech Ltd.
Debt-to-Equity Ratio 28.18 9.28 Tanfac Industries Ltd.
PEG Ratio -2.83 -0.85 Tanfac Industries Ltd.
EV/EBITDA 12.22 41.73 Rossari Biotech Ltd.
Profit Margin (TTM) 6.01% 10.85% Tanfac Industries Ltd.
Operating Margin (TTM) 8.47% 12.17% Tanfac Industries Ltd.
EBITDA Margin (TTM) 8.47% 12.17% Tanfac Industries Ltd.
Return on Equity 11.50% 28.25% Tanfac Industries Ltd.
Return on Assets (TTM) 7.19% 20.67% Tanfac Industries Ltd.
Free Cash Flow (TTM) $-210.69M $-641.87M Rossari Biotech Ltd.
Dividend Yield 6.54% 0.34% Rossari Biotech Ltd.
1-Year Return -21.83% 29.08% Tanfac Industries Ltd.
Price-to-Sales Ratio (TTM) 1.25 7.19 Rossari Biotech Ltd.
Enterprise Value $31.35B $49.64B Tanfac Industries Ltd.
EV/Revenue Ratio 1.37 7.20 Rossari Biotech Ltd.
Gross Profit Margin (TTM) 31.10% 36.49% Tanfac Industries Ltd.
Revenue per Share (TTM) $414 $346 Rossari Biotech Ltd.
Earnings per Share (Diluted) $24.84 $37.53 Tanfac Industries Ltd.
Beta (Stock Volatility) 0.33 -0.21 Tanfac Industries Ltd.

Rossari Biotech Ltd. vs Tanfac Industries Ltd. Stock Performance Analysis

Loading Price Chart...

ROSSARI
TANFACIND

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Rossari Biotech Ltd.-2.83%-0.02%13.32%12.09%-9.82%-6.13%
Tanfac Industries Ltd.-2.08%3.72%-15.95%0.07%2.17%-4.61%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Rossari Biotech Ltd.-21.83%-31.80%-59.01%-29.04%-29.04%-29.04%
Tanfac Industries Ltd.29.08%107.16%1,664.40%11,884.41%13,950.69%11,143.65%

Performance & Financial Health Analysis: Rossari Biotech Ltd. vs Tanfac Industries Ltd.

MetricROSSARITANFACIND
Market Information
Market Cap i₹28.60B₹49.61B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i230,27722,308
90 Day Avg. Volume i146,21216,696
Last Close₹528.25₹2,012.00
52 Week Range₹375.00 - ₹766.00₹1,450.55 - ₹2,585.00
% from 52W High-31.04%-22.17%
All-Time High₹1,619.00 (Oct 11, 2021)₹5,064.30 (Aug 29, 2025)
% from All-Time High-67.37%-60.27%
Growth Metrics
Quarterly Revenue Growth0.13%-0.03%
Quarterly Earnings Growth0.03%-0.55%
Financial Health
Profit Margin (TTM) i0.06%0.11%
Operating Margin (TTM) i0.08%0.12%
Return on Equity (TTM) i0.12%0.28%
Debt to Equity (MRQ) i28.189.28
Cash & Liquidity
Book Value per Share (MRQ)₹226.03₹170.18
Cash per Share (MRQ)₹13.87₹14.38
Operating Cash Flow (TTM) i₹440.09M₹523.26M
Levered Free Cash Flow (TTM) i₹1.36B₹881.47M
Dividends
Last 12-Month Dividend Yield i6.54%0.34%
Last 12-Month Dividend i₹43.78₹16.00

Valuation & Enterprise Metrics Analysis: Rossari Biotech Ltd. vs Tanfac Industries Ltd.

MetricROSSARI (Apr 26, 2026)TANFACIND (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i20.7966.26
Forward P/E i17.98N/A
PEG Ratio i-2.83-0.85
Price to Sales (TTM) i1.257.19
Price to Book (MRQ) i2.2814.61
Market Capitalization
Market Capitalization i₹28.60B₹49.61B
Enterprise Value i₹31.35B₹49.64B
Enterprise Value Metrics
Enterprise to Revenue i1.377.20
Enterprise to EBITDA i12.2241.73
Risk & Other Metrics
Beta i0.33-0.21
Book Value per Share (MRQ) i₹226.03₹170.18

Financial Statements Comparison: Rossari Biotech Ltd. vs Tanfac Industries Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricROSSARI (2025)TANFACIND (2025)
Revenue/Sales i20.71B5.51B
Cost of Goods Sold i14.50B3.18B
COGS % of Revenue i70.0%57.8%
Gross Profit i6.22B2.32B
Gross Margin i30.0%42.2%
Research & Development iN/AN/A
Operating Income (EBIT) i1.87B1.21B
Operating Margin i9.0%22.0%
EBITDA i2.68B1.29B
EBITDA Margin i13.0%23.4%
Pre-Tax Income i1.85B1.19B
Pre-Tax Income % of Revenue i8.9%21.6%
Income Tax i488.07M306.14M
Income Tax % of Revenue i2.4%5.6%
Net Income (Profit) i1.36B881.47M
Profit Margin i6.6%16.0%

Balance Sheet & Liquidity Metrics

MetricROSSARI (2025)TANFACIND (2025)
Cash & Equivalents i442.02M301.18M
Total Current Assets i10.42B2.46B
Total Current Assets % of Revenue i50.3%44.8%
Total Current Liabilities i5.37B1.08B
Total Current Liabilities % of Revenue i25.9%19.6%
Long-Term Debt i1.22BN/A
Long-Term Debt % of Revenue i5.9%0.0%
Total Shareholders Equity i11.85B3.12B
Retained Earnings i6.97B2.62B
Retained Earnings % of Revenue i33.7%47.6%
Property, Plant & Equipment i01.68B

Cash Flow Statement Comparison

MetricROSSARI (2025)TANFACIND (2025)
Operating Cash Flow i440.09M523.26M
Operating Cash Flow % of Revenue i2.1%9.5%
Capital Expenditures i-1.58B-968.83M
Free Cash Flow i-210.69M-641.87M
FCF Margin i-1.0%-11.7%
Debt Repayment i-385.79MN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricROSSARITANFACIND
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i55.38M19.95M
Float Shares i17.63M7.01M
% Held by Insiders i68.15%70.86%
% Held by Institutions i18.64%0.03%
% Held by Public i13.21%29.11%

Dividend Analysis & Yield Comparison: Rossari Biotech Ltd. vs Tanfac Industries Ltd.

MetricROSSARITANFACIND
Last 12-Month Dividend i₹43.78₹16.00
Last 12-Month Dividend Yield i6.54%0.34%
3-Year Avg Annual Dividend i₹14.93₹7.50
3-Year Avg Dividend Yield i1.66%0.30%
3-Year Total Dividends i₹44.78₹22.50
Ex-Dividend DateJun 20, 2025Sep 17, 2025